enVVeno Medical Corporation (NVNO) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

-49.7%

$3.46

vs $6.87 price

Levered DCF

$4.02

After debt service

Piotroski score

1 / 9

Weak

Altman Z-score

-13.74

Distress zone

Rating

B-

Overall 3 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
P/E	-0.34×	-0.07×	-0.08×	-0.07×	-0.1×	-0.03×	-0.03×	-0.02×
P/B	0.25×	0.04×	0.04×	0.04×	0.03×	0.05×	0.25×	0.2×
P/S	0×	0×	0×	0×	0×	0×	8.05×	2.15×
EV / EBITDA	-0.23×	-0.04×	0.02×	0.05×	3.18×	0.93×	0.03×	0.39×
Gross margin	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	100.0%	100.0%
Operating margin	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	-24566.5%	-4210.5%
Net margin	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	-24406.7%	-6991.5%
Current ratio	13.58×	20.88×	34.23×	25.78×	34.83×	3×	0.76×	1.86×
Debt / equity	0.03×	0.03×	0.03×	0.04×	0.04×	0.12×	0.87×	0×
Interest coverage	0×	0×	0×	0×	0×	2,443.2×	-8,226.49×	-1.14×
Dividend yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Payout ratio	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%

Key metrics by fiscal year

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
Return on equity	-71.8%	-51.8%	-50.9%	-63.7%	-30.4%	-128.7%	-770.3%	-640.5%
Return on invested capital	-75.1%	-55.1%	-53.0%	-61.6%	-29.9%	-114.5%	-415.7%	-385.7%
Return on assets	-65.9%	-48.5%	-48.4%	-59.2%	-28.6%	-86.7%	-222.0%	-366.4%
Free cash flow yield	-231.9%	-1124.0%	-1030.2%	-947.3%	-736.4%	-2426.0%	-2488.6%	-1588.5%
Earnings yield	-290.0%	-1453.3%	-1282.5%	-1485.3%	-996.3%	-2820.6%	-3031.2%	-3253.3%
Enterprise value	$4.3M	$811.3K	-$384.3K	-$1.2M	-$51.1M	-$8.1M	-$199K	-$2.3M
Net debt / EBITDA	0.12×	0.03×	0.1×	0.12×	3.28×	0.97×	0.06×	0.45×
Cash conversion cycle (days)	0	-695	-285	-451	-451	-1,322	0	63